MedTrace Logo

Patient Specific Optimized Therapy (PSOT)

NCT03858361 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 566

Last updated 2023-06-08

No results posted yet for this study

Summary

Data collection from atrial flutter patients before, during and after undergoing catheter-based electrophysiological (EP) intervention in order to develop a patient specific optimized therapy (PSOT) to improve specific patient's arrhythmia treatment for Atrial Flutter.

Conditions

  • Data Collection

Interventions

DEVICE

Atrial Flutter Ablation

Catheter-based electrophysiological (EP) intervention.

Sponsors & Collaborators

  • EPD Solutions, A Philips Company

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-13
Primary Completion
2023-03-28
Completion
2023-03-28
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03858361 on ClinicalTrials.gov